The peptide and anticoagulant drugs market is projected to register a CAGR of 3.3% during the forecast period (2022-2028). Peptides are a chain of amino acids. Anticoagulants are blood thinners that prevent coagulation of blood, prolonging the clotting time. The peptide and anticoagulant drugs are used for myocardial infarction, pulmonary embolism, stroke, and others. Increasing healthcare expenditure is one of the driving factors in boosting the growth of the peptide and anticoagulant drug market. For instance, according to the data published by the Centre for Medicare and Medicaid Services (CMS), the US health expenditure grew by $9.7 to $4.1 trillion in 2020 and accounted for 19.1% of Gross Domestic Product (GDP). Similarly, Medicare spending grew by 3.5% to $829.1 billion in 2020 which is 20 % of total national health expenditure. Whereas, Medicaid spending grew by 9.2% to $671.2 billion in 2020, which is 16 % of total national health expenditure. Moreover, according to CMS, national health spending is anticipated to grow at an average annual rate of 5.4 % and to reach $6.2 trillion by 2028.
To Request a Sample of our Report on Peptide and Anticoagulant Drug Market: https://www.omrglobal.com/request-sample/peptide-and-anticoagulant-market
The global peptide and anticoagulant drug market are segmented based on product and application. Based on the product, the market is further sub-segmented into Hormonal, antibiotic, antifungal, ACE inhibitor, others. Based on application, the market is sub-segmented into diabetes, cancer, osteoporosis, cardiology, gynecology, infectious diseases, others. Among these, the antibiotics segment is expected to hold a considerable share in the market during the forecast period owing to an incline in bacterial infections.
(Get 15% Discount on Buying this Report)
A full Report of Peptide and Anticoagulant Drug Market is Available @ https://www.omrglobal.com/industry-reports/peptide-and-anticoagulant-market
Global Peptide and anticoagulant drug Market Segmentation
By Product
- Antibiotics
- Antifungal
- ACE Inhibitor
- Hormonal
By application
- Cardiology
- Gynecology
- Diabetes
- Cancer
- Osteoporosis
- Infectious Diseases
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Amgen,Inc
- Aspen Pharmacare Holdings, Ltd.
- AmbioPharm,Inc.
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Co.
- Biofera Laboratories Pvt Ltd.
- BACHEM AG
- Daiichi Sankyo Co.
- EVER Pharma
- Dr.Reddys Laboratories , Ltd.
- LEO Pharma A/S
- SANOFI
- Novartis AG
- Novo Nordisk A/S
- Takeda Pharmacuetical Co ,Ltd.
- Teva Pharmaceutical Industries
- Wockhardt Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
